A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ER / expression of oestrogen receptor

[Related PubMed/MEDLINE]
Total Number of Papers: 136
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ER  (>> Co-occurring Abbreviation)
Long Form:   expression of oestrogen receptor
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Achieving CLARITY on bisphenol A, brain and behaviour. BPA, CLARITY-BPA, Core study, NTP
2019 Biological differences between focal and diffuse adenomyosis and response to hormonal treatment. GnRHa, PR
2019 Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds. ---
2019 New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer. HER2, PR, TNBC
2019 Oestradiol acts through its beta receptor to increase vasopressin neuronal activation and secretion induced by dehydration. PVN, WD
2019 Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining. IHC, PgR
2019 The selective oestrogen receptor modulator, bazedoxifene, mimics the neuroprotective effect of 17beta-oestradiol in diabetic ischaemic stroke by modulating oestrogen receptor expression and the MAPK/ERK1/2 signalling pathway. BZA, MAPK/ERK
2019 Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain. BMP
2018 Identification of oestrogen, progesterone receptor and human epidermal growth factor receptor 2 expression in mediastinal metastases of breast cancer obtained by endobronchial ultrasound-guided transbronchial needle aspiration. EBUS-TBNA, HER2, PR
10  2018 Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype. ALDH, HR, PR, TNBC
11  2018 Myofibroblastoma of the breast. AR, PR
12  2018 Rare paratesticular aggressive angiomyxoma with negative oestrogen and progesterone receptors in a male patient. AAM, PR, SMA
13  2018 Role of oestrogen receptor-alpha and -beta in bladder tissue of patients with a clinical diagnosis of benign prostatic hyperplasia. BPH, IHC, IPSS, LUTS, PVR, TURP
14  2017 Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen. ALN, PR
15  2017 Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation. HER2, POPDC1, PR
16  2017 Effects of electroacupuncture on uterine morphology and expression of oestrogen receptors in ovariectomised rats. EA, qRT-PCR, UWW/BW
17  2017 Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome. PgR
18  2017 Recurrence dynamics of breast cancer according to baseline body mass index. BMI
19  2017 The genetic landscape of breast carcinomas with neuroendocrine differentiation. NBCs
20  2016 A Quantification of the Injury-Induced Changes in Central Aromatase, Oestrogenic Milieu and Steroid Receptor Expression in the Zebra Finch. ---
21  2016 Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours. GCDFP-15, PR, TTF-1, WT1
22  2016 MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression. ---
23  2016 Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers. HR
24  2016 Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem. ---
25  2016 uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R. HER2, IGF1R, PR, TNBC, uPAS
26  2015 Asynchronous glands in secretory pattern endometrium: clinical associations and immunohistological changes. non-secretory, PR
27  2015 Clinical management of breast cancer heterogeneity. PR
28  2015 Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone. AR, FDG, PET
29  2015 Defining optimal duration and predicting benefit from chemotherapy in patients with luminal-like subtypes. ---
30  2015 Effects of reproductive experience on central expression of progesterone, oestrogen alpha, oxytocin and vasopressin receptor mRNA in male California mice (Peromyscus californicus). BNST, MeA, MPOA, OTR, PR
31  2015 Phosphorylation Alters Oestrogen Receptor beta-Mediated Transcription in Neurones. ---
32  2015 S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer. IHC, OS, PFS, PR, TNBC
33  2015 The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease. DPN, GnRH, HD, HPA
34  2015 Triple negative breast cancer: looking for the missing link between biology and treatments. HER2, PR, TNBC
35  2014 17beta-oestradiol enhances global DNA hypomethylation in CD4-positive T cells from female patients with lupus, through overexpression of oestrogen receptor-alpha-mediated downregulation of DNMT1. DNMT1, SLE
36  2014 Characterization of aromatase expression in the adult male and female mouse brain. I. Coexistence with oestrogen receptors alpha and beta, and androgen receptors. AR, EGFP
37  2014 Oestrogen receptors beta1 and betacx have divergent roles in breast cancer survival and lymph node metastasis. ---
38  2014 Sex differences in expression of oestrogen receptor alpha but not androgen receptor mRNAs in the foetal lamb brain. AR, oSDN
39  2014 The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. CLG, MAOA
40  2014 Unilateral lesion increases oestrogen receptor alpha expression in the intact side of the ventromedial hypothalamic nucleus in ovariectomised rats. ARC, vlVMN
41  2013 Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts. HER
42  2013 Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation. FISH, qPCR
43  2013 ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up. BC, ERM, PgR
44  2013 Positron emission tomography imaging of oestrogen receptor-expression in endometrial stromal sarcoma supports oestrogen receptor-targeted therapy: case report and review of the literature. ESSs, FES, PET/CT, RECIST
45  2013 Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: results of an exploratory analysis. CI, HR, MBC, TTP
46  2012 Anatomically-specific actions of oestrogen receptor in the developing female rat brain: effects of oestradiol and selective oestrogen receptor modulators on progestin receptor expression. MPN, PR, PRir, SERMs, VMN
47  2012 Identification of telocytes in the upper lamina propria of the human urinary tract. IC, PR, ULP
48  2012 Interaction between P2X3 and oestrogen receptor (ER)alpha/ERbeta in ATP-mediated calcium signalling in mice sensory neurones. alpha,beta-me, DRG, KO
49  2012 Low expression of NQO1 predicts pathological complete response to neoadjuvant chemotherapy in breast cancer patients treated with TAC regimen. EGFR and HER2, MDR1, NCT, NQO1, pCR, PR
50  2012 Oestrogen receptor beta in adenoid cystic carcinoma of salivary glands. ACC
51  2012 Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes. ATP, CSRAs, PR, TMA
52  2012 The Immunohistochemical Expression of the Oestrogen Receptor (ER), HER-2/NEU and Cytokeratin 8/18 and 5/6 in Invasive Breast Carcinoma. ---
53  2011 Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy. AIs, PET, PR
54  2011 ER-alpha agonist induces conversion of fibroblasts into myofibroblasts, while ER-beta agonist increases ECM production and wound tensile strength of healing skin wounds in ovariectomised rats. ERT, HDF, TS
55  2011 Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice. AIB1, FC, FS, HER2, IGF-1R, pHER2, TAM
56  2011 Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. CK, PR
57  2011 Oestradiol supplement minimises coronary occlusion-induced myocardial infarction and ventricular dysfunction in oophorectomised female rats. cTnI, SBP
58  2011 Oestrogen prevents cardiomyocyte apoptosis by suppressing p38alpha-mediated activation of p53 and by down-regulating p53 inhibition on p38beta. I/R, p38alpha MAPK, ROS
59  2011 The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ. BCS, DCIS
60  2010 Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression. SFK
61  2010 Expression and mutational analysis of GATA3 in Malaysian breast carcinomas. LN, PR
62  2010 Expression and prognostic significance of CK19 in canine malignant mammary tumours. ---
63  2010 Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma. IMC, PR, VEGF
64  2010 High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. CNG
65  2010 Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status. IHC
66  2010 Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. miRNA
67  2010 Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. ECs, EMT, L1CAM, PR
68  2009 BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. ---
69  2009 Differential expression of oestrogen receptor alpha following reproductive experience in young and middle-aged female rats. ---
70  2008 Changes in tumour biological markers during primary systemic chemotherapy (PST). Bcl-2, PR, PST
71  2008 Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis. AR, VLS
72  2008 Estrogens and growth. ---
73  2008 Expression and regulation of oestrogen receptors in the human corpus luteum. hCG
74  2008 Expression of mRNAs encoding oestrogen receptor (ER) alpha and ERbeta, androgen receptor and progesterone receptor during gonadal and follicular development in the marsupial brushtail possum (Trichosurus vulpecula). AR, PR
75  2008 HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information. HER2, PR
76  2008 Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer. ---
77  2008 Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. CK, FFPE, PR
78  2008 Stimulation of oestrogen receptor-expressing endothelial cells with oestrogen reduces proliferation of cocultured vascular smooth muscle cells. EC, FCS, VSMC
79  2007 Cerebrovascular effects of oestrogen: multiplicity of action. COX, eNOS, iNOS, NF, NO
80  2007 Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast. CK, EGFR, HPV, PCR, PR, SCC
81  2007 Expression of oestrogen receptor-beta in apocrine carcinomas of the breast. AR, PR
82  2007 Oestrogen receptor alpha is required for biochanin A-induced apolipoprotein A-1 mRNA expression in HepG2 cells. PK
83  2007 The integrated action of oestrogen receptor isoforms and sites with progesterone receptor in the gonadotrope modulates LH secretion: evidence from tamoxifen-treated ovariectomized rats. DPN, LHRH, PPT, PR, TX
84  2006 Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomas. DC, FISH, RI
85  2006 Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications. EGFR
86  2005 A paradoxical inhibitory effect of oestradiol-17beta on GnRH self-priming in pituitaries from tamoxifen-treated rats. TX
87  2005 Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. ABC, CCND1, PgR
88  2005 Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade. PgR
89  2005 Expression of oestrogen receptors alpha and beta and of aromatase in the testis of immature and mature boars. IHC, RT-PCR
90  2005 Gonadotrope oestrogen receptor-alpha and -beta and progesterone receptor immunoreactivity after ovariectomy and exposure to oestradiol benzoate, tamoxifen or raloxifene in the rat: correlation with LH secretion. PR, RX, SERM, TX
91  2005 Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. PR
92  2005 Oestrogen receptor beta-immunoreactive neurones in the ovine hypothalamus: distribution and colocalisation with gonadotropin-releasing hormone. GnRH
93  2004 COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. COX-2, DCIS, IBC
94  2004 Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer. CYCLD1, STS
95  2004 Polymorphisms in oestrogen and progesterone receptor genes: possible influence on prolactin levels in women. PgR, PROGINS
96  2004 Sex and region-specific regulation of oestrogen receptor beta in the rat hypothalamus. ---
97  2004 Sex steroid receptors in rheumatoid arthritis. AR, PR, RA, RT-PCR
98  2004 The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts. ---
99  2003 Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) alpha and beta in bone fractures from men and women. ---
100  2003 Oestradiol-dependent and -independent modulation of tyrosine hydroxylase mRNA levels in subpopulations of A1 and A2 neurones with oestrogen receptor (ER)alpha and ER beta gene expression. LHRH, TH